Real-Life Active Surveillance of a Naphazoline/ Hypromellose Fixed Combination's Safety Profile in Peruvian Population.

Homero Contreras-Salinas Mariana Barajas-HernándezLeopoldo Martín Baiza-DuránVanessa Orozco-CejaLourdes Yolotzin Rodríguez-Herrera

Published in: Integrated pharmacy research & practice (2021)

The low incidence of ADRs, their short recovery time, and their categorization as "mild" and "not serious" demonstrates the high tolerability in the studied population; therefore, according to the study, the safety profile for NAPH seems to be adequate, with a suitable tolerability.

Keyphrases

open label
risk factors
double blind
clinical trial
randomized controlled trial
placebo controlled